Showing 1 - 10 of 41,019
Persistent link: https://www.econbiz.de/10014328020
Persistent link: https://www.econbiz.de/10001786493
Persistent link: https://www.econbiz.de/10012816525
Persistent link: https://www.econbiz.de/10012512495
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844
Persistent link: https://www.econbiz.de/10012242289
Persistent link: https://www.econbiz.de/10012506948
The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate...
Persistent link: https://www.econbiz.de/10011721586
Persistent link: https://www.econbiz.de/10011748246
Persistent link: https://www.econbiz.de/10011708133